709 related articles for article (PubMed ID: 4357610)
1. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
Blonde L; Wehmann RE; Steiner AL
J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
[TBL] [Abstract][Full Text] [Related]
2. Sources of cyclic nucleotides in plasma.
Wehmann RE; Blonde L; Steiner AL
J Clin Invest; 1974 Jan; 53(1):173-9. PubMed ID: 4357611
[TBL] [Abstract][Full Text] [Related]
3. Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.
Broadus AE; Kaminsky NI; Hardman JG; Sutherland EW; Liddle GW
J Clin Invest; 1970 Dec; 49(12):2222-36. PubMed ID: 5480849
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and excretion of exogenous adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate. Studies in the isolated perfused rat kidney and in the intact rat.
Coulson R
J Biol Chem; 1976 Aug; 251(16):4958-67. PubMed ID: 182688
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium nitroprusside on renal functions and NO-cGMP production in anesthetized dogs.
Tanahashi M; Sekizawa T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
J Cardiovasc Pharmacol; 1999 Mar; 33(3):401-8. PubMed ID: 10069675
[TBL] [Abstract][Full Text] [Related]
6. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
Gill JR; Casper AG
J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
[TBL] [Abstract][Full Text] [Related]
8. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
[TBL] [Abstract][Full Text] [Related]
9. 2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.
Jackson EK; Mi Z; Janesko-Feldman K; Jackson TC; Kochanek PM
Am J Physiol Regul Integr Comp Physiol; 2019 Jun; 316(6):R783-R790. PubMed ID: 30789788
[TBL] [Abstract][Full Text] [Related]
10. Renal and systemic effects of synthetic atrial natriuretic factor.
Seymour AA; Blaine EH; Mazack EK; Smith SG; Stabilito II; Haley AB; Napier MA; Whinnery MA; Nutt RF
Life Sci; 1985 Jan; 36(1):33-44. PubMed ID: 2981380
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
[TBL] [Abstract][Full Text] [Related]
12. Effects of acetazolamide and changes of acid-base balance on the content of cyclic nucleotides in the rat kidney.
Osswald H; Hawlina A
Pharmacology; 1979; 19(1):44-50. PubMed ID: 229499
[TBL] [Abstract][Full Text] [Related]
13. [Cyclic nucleotides (cAMP and cGMP) in the dog plasma during extracorporeal hemocarboperfusion].
Koterov AN; Nikol'skiĭ AV; Romantsev EF; Vernigorova LA
Biull Eksp Biol Med; 1982 Sep; 94(9):45-7. PubMed ID: 6293619
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.
Gennari C; Francini G; Galli M; Lore F
J Clin Pathol; 1978 Aug; 31(8):735-41. PubMed ID: 211147
[TBL] [Abstract][Full Text] [Related]
15. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.
Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP
Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347
[TBL] [Abstract][Full Text] [Related]
16. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats.
Conrad KP; Vernier KA
Am J Physiol; 1989 Oct; 257(4 Pt 2):R847-53. PubMed ID: 2552845
[TBL] [Abstract][Full Text] [Related]
17. Effect of adrenomedullin on renal hemodynamics and functions in dogs.
Ebara T; Miura K; Okumura M; Matsuura T; Kim S; Yukimura T; Iwao H
Eur J Pharmacol; 1994 Sep; 263(1-2):69-73. PubMed ID: 7821363
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II.
Torres VE; Northrup TE; Edwards RM; Shah SV; Dousa TP
J Clin Invest; 1978 Dec; 62(6):1334-43. PubMed ID: 219028
[TBL] [Abstract][Full Text] [Related]
19. Hyperkalemia, hyperglycemia, and plasma levels of cyclic AMP and cyclic GMP induced by portal vein injection of cyclic nucleotides and their butyryl derivatives into dogs.
Nakashima T; Morita N; Nakanishi Y; Inoki M; Kurogochi Y
Can J Physiol Pharmacol; 1982 Dec; 60(12):1584-91. PubMed ID: 6299491
[TBL] [Abstract][Full Text] [Related]
20. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
